Feliza Mirasol

Feliza Mirasol is the science editor for BioPharm International.

Articles

AbbVie Acquires Landos Biopharma and Gets Full FDA Nod for ADC Product

AbbVie’s acquisition of Landos includes a lead asset that boosts its portfolio in autoimmune and inflammatory diseases, while the ADC, ELAHERE, gets full FDA approval.